AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Kalkinemedia

Published November 13, 2026 · Updated November 14, 2026

Entropy Neurodynamics Updates Constitution to Cap Employee Incentive Plan at 10% After ...

Read the full story at Kalkinemedia

Entropy Neurodynamics (ASX:ENP) ENP (ASX:ENP) , a clinical-stage biotech firm specializing in precision-controlled psychedelic therapies, has.

Post on X

Share this story

Surfaced by this Google Alert

Psychedelic biotech